Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

2-chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.
FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons.
Impact of sleep disorder treatment on fatigue in multiple sclerosis.
Drug Safety Labeling Changes
Power estimation for non-standardized multisite studies.
Biogen Idec's PLEGRIDY™ (peginterferon beta-1a) approved in the US for the treatment of multiple sclerosis
Tecfidera(®): an approach for repurposing.
Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate.
Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
Rituximab in paediatric onset multiple sclerosis: a case series.
Architecture of human mTOR complex 1.
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.
Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.
The role of T cell apoptosis in nervous system autoimmunity.
Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
Acorda Therapeutics announces issuance of additional U.S. Patent for AMPYRA® covering a range of dosage strengths
Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy.
IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis.
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors.
Antiinflammatory effects of orientin-2″-o-galactopyranoside on lipopolysaccharide-stimulated microglia.
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial.
Reviewing the Unmet Needs of Patients with Multiple Sclerosis.
Effects of an aqueous extract of North American ginseng on MOG((35-55))-induced EAE in mice.

Pages